Earlier this year, Haleon agreed to sell its ChapStick lip balm brand in a deal worth around 510 million US dollars (£383 million), while it sold off athlete’s foot treatment Lamisil last year.

Although ibogaine gained popularity in the U.S. and Europe in the 1980s as a non-addictive treatment for drug dependency, it’s still classified as a Schedule I substance under the Controlled ...

Perry Kendall was a cofounder of Fair Price Pharma, a not-for-profit dedicated to providing low-cost Canadian access to diacetylmorphine morphine as a treatment option for individuals whose ...

About one in 300 people worldwide are affected by schizophrenia, but for decades treatment options have been both static and limited. If the FDA approves the twice-daily pill on Thursday ...

The global tinea pedis treatment market is on a robust growth trajectory, projected to reach a market value of USD 2,484 million by 2034, from an estimated USD 1,496.3 million in 2024. According to ...